Lau, Edmund M. T.
Giannoulatou, Eleni
Celermajer, David S.
Humbert, Marc
Article History
First Online: 8 June 2017
Competing interests
: E.M.T.L. has relationships with Actelion, AstraZeneca, GSK, and Menarini. Relationships include serving on speaker bureaus, consultancy on advisory boards, and research funding support. D.S.C. received support from Actelion, including serving on the speaker bureau and funding for research. M.H. has relationships with drug companies including Actelion, Bayer, GSK, Merck, Novartis, Pfizer, and United Therapeutics. In addition to being an investigator in trials involving these companies, relationships include consultancy service and membership of scientific advisory boards. E.G. declares no competing interests.